MedTrace Logo

Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females

NCT03052413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2019-01-02

No results posted yet for this study

Summary

The objective of this study is to assess the safety and effectiveness of a nutraceutical supplement for the treatment of hair loss and thinning in females over the course of six months of continuous daily use.

Conditions

Interventions

DIETARY_SUPPLEMENT

Nutrafol

Eligible subjects will receive Nutrafol® to take daily for 180 days

DIETARY_SUPPLEMENT

placebo

Eligible subjects will receive Placebo to take daily for 180 days

Sponsors & Collaborators

  • Sadick Research Group

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2017-11-10
Completion
2017-11-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03052413 on ClinicalTrials.gov